Artificial Intelligence Uncovered Clinical Factors for Cardiovascular Events in Myocardial Infarction Patients with Glucose Intolerance.

Journal: Cardiovascular drugs and therapy
PMID: 32399803

Abstract

PURPOSE: Glucose intolerance (GI), defined as either prediabetes or diabetes, promotes cardiovascular events in patients with myocardial infarction (MI). Using the pooled clinical data from patients with MI and GI in the completed ABC and PPAR trials, we aimed to identify their clinical risk factors for cardiovascular events.

Authors

  • Kazuhiro Shindo
    Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA.
  • Hiroki Fukuda
    Department of Clinical Research and Development, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, Japan.
  • Tatsuro Hitsumoto
    Department of Clinical Research and Development, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, Japan.
  • Yohei Miyashita
    Department of Legal Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan.
  • Jiyoong Kim
    Kim Cardiovascular Clinic, 3-6-8 Katsuyama, Tennoji-ku, Osaka, Japan.
  • Shin Ito
    Department of Clinical Research and Development, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, Japan.
  • Takashi Washio
    The Institute of Scientific and Industrial Research, Osaka University, 8-1 Mihogaoka, Ibaraki, Osaka, 567-0047, Japan.
  • Masafumi Kitakaze
    Department of Clinical Medicine and Development, and Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Centre, Osaka 565-0873, Japan. kitakaze@zf6.so-net.ne.jp.

Keywords

External Resources

Popular Topics
Recent Journals